is mounjaro tirzepatide second obesity drug to be approved for use in England | Obesity FDA approves new version of

Wegovy users are advised to stop the drug as soon as a pregnancy is detected, while Ozempic users, ostensibly taking the drug for its indicated diabetes use, may continue only if the potential benefit justifies the potential risk to the fetus, according to the Ozempic label

Oral tirzepatide is a medication that mimics incretin hormones to help regulate blood sugar levels and control appetite

It is often referred to as the silent killer because it typically presents no noticeable symptoms, yet it increases the risk of heart disease, stroke, and other serious conditions

Its primary function is to optimize how your body handles insulin

Wegovy is FDA-approved for chronic weight management in adults with obesity or weight-related conditions